» Articles » PMID: 15668740

Human Lupus Autoantibody-DNA Complexes Activate DCs Through Cooperation of CD32 and TLR9

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2005 Jan 26
PMID 15668740
Citations 317
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by pathogenic autoantibodies against nucleoproteins and DNA. Here we show that DNA-containing immune complexes (ICs) within lupus serum (SLE-ICs), but not protein-containing ICs from other autoimmune rheumatic diseases, stimulates plasmacytoid DCs (PDCs) to produce cytokines and chemokines via a cooperative interaction between Toll-like receptor 9 (TLR9) and FcgammaRIIa (CD32). SLE-ICs transiently colocalized to a subcellular compartment containing CD32 and TLR9, and CD32+, but not CD32-, PDCs internalized and responded to SLE-ICs. Our findings demonstrate a novel functional interaction between Fc receptors and TLRs, defining a pathway in which CD32 delivers SLE-ICs to intracellular lysosomes containing TLR9, inducing a signaling cascade leading to PDC activation. These data demonstrate that endogenous DNA-containing autoantibody complexes found in the serum of patients with SLE activate the innate immune system and suggest a novel mechanism whereby these ICs contribute to the pathogenesis of this autoimmune disease.

Citing Articles

Ultraviolet Radiation-Induced Tolerogenic Dendritic Cells in Skin: Insights and Mechanisms.

Ghajar-Rahimi G, Yusuf N, Xu H Cells. 2025; 14(4).

PMID: 39996779 PMC: 11854269. DOI: 10.3390/cells14040308.


FPR1 affects acute rejection in kidney transplantation by regulating iron metabolism in neutrophils.

Li P, Ji W, Zhang B, Jia H, Wang J, Sun Z Mol Med. 2025; 31(1):23.

PMID: 39849390 PMC: 11758745. DOI: 10.1186/s10020-025-01077-w.


The Role of Podocytes in Lupus Pathology.

Maeda K, Abdi R, Tsokos G Curr Rheumatol Rep. 2024; 27(1):10.

PMID: 39731699 DOI: 10.1007/s11926-024-01175-4.


Type I IFN drives unconventional IL-1β secretion in lupus monocytes.

Caielli S, Balasubramanian P, Rodriguez-Alcazar J, Balaji U, Robinson L, Wan Z Immunity. 2024; 57(11):2497-2513.e12.

PMID: 39378884 PMC: 11563874. DOI: 10.1016/j.immuni.2024.09.004.


Interferon Inhibition in SLE: From Bench to Bedside.

Deligeorgakis D, Skouvaklidou E, Adamichou C Mediterr J Rheumatol. 2024; 35(Suppl 2):354-364.

PMID: 39193183 PMC: 11345605. DOI: 10.31138/mjr.010324.iis.


References
1.
Ronnblom L, Alm G . A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med. 2001; 194(12):F59-63. PMC: 2193578. DOI: 10.1084/jem.194.12.f59. View

2.
Antequera F, Bird A . Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A. 1993; 90(24):11995-9. PMC: 48112. DOI: 10.1073/pnas.90.24.11995. View

3.
Tesch G, Maifert S, Schwarting A, Rollins B, Kelley V . Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999; 190(12):1813-24. PMC: 2195716. DOI: 10.1084/jem.190.12.1813. View

4.
Aderem A, Ulevitch R . Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797):782-7. DOI: 10.1038/35021228. View

5.
Bave U, Alm G, Ronnblom L . The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol. 2000; 165(6):3519-26. DOI: 10.4049/jimmunol.165.6.3519. View